These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35787229)

  • 1. The industrial design, translation, and development strategies for long-acting peptide delivery.
    Yang B; Gomes Dos Santos A; Puri S; Bak A; Zhou L
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1233-1245. PubMed ID: 35787229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery.
    Zhang C; Yang L; Wan F; Bera H; Cun D; Rantanen J; Yang M
    Int J Pharm; 2020 Jul; 585():119441. PubMed ID: 32442645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying.
    Wan F; Yang M
    Int J Pharm; 2016 Feb; 498(1-2):82-95. PubMed ID: 26688034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules.
    Gonella A; Grizot S; Liu F; López Noriega A; Richard J
    Expert Opin Drug Deliv; 2022 Aug; 19(8):927-944. PubMed ID: 35899474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and Evolving Techniques for the Characterization of Peptide Therapeutics.
    D'Addio SM; Bothe JR; Neri C; Walsh PL; Zhang J; Pierson E; Mao Y; Gindy M; Leone A; Templeton AC
    J Pharm Sci; 2016 Oct; 105(10):2989-3006. PubMed ID: 27499338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on parenteral delivery of peptides and proteins.
    Jain D; Mahammad SS; Singh PP; Kodipyaka R
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1403-1420. PubMed ID: 31215293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug eluting implants in pharmaceutical development and clinical practice.
    Johnson AR; Forster SP; White D; Terife G; Lowinger M; Teller RS; Barrett SE
    Expert Opin Drug Deliv; 2021 May; 18(5):577-593. PubMed ID: 33275066
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained Release Systems for Delivery of Therapeutic Peptide/Protein.
    Nie T; Wang W; Liu X; Wang Y; Li K; Song X; Zhang J; Yu L; He Z
    Biomacromolecules; 2021 Jun; 22(6):2299-2324. PubMed ID: 33957752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
    Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities.
    Bassand C; Villois A; Gianola L; Laue G; Ramazani F; Riebesehl B; Sanchez-Felix M; Sedo K; Ullrich T; Duvnjak Romic M
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1265-1283. PubMed ID: 35877189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation strategies for sustained release of proteins.
    Lewis AL; Illum L
    Ther Deliv; 2010 Sep; 1(3):457-79. PubMed ID: 22816145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel delivery systems for improving the clinical use of peptides.
    Kovalainen M; Mönkäre J; Riikonen J; Pesonen U; Vlasova M; Salonen J; Lehto VP; Järvinen K; Herzig KH
    Pharmacol Rev; 2015 Jul; 67(3):541-61. PubMed ID: 26023145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in oral delivery of peptide hormones.
    Varamini P; Toth I
    Expert Opin Drug Deliv; 2016; 13(4):507-22. PubMed ID: 26787260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery.
    Butreddy A; Gaddam RP; Kommineni N; Dudhipala N; Voshavar C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically established biodegradable long acting injectables: An industry perspective.
    Nkanga CI; Fisch A; Rad-Malekshahi M; Romic MD; Kittel B; Ullrich T; Wang J; Krause RWM; Adler S; Lammers T; Hennink WE; Ramazani F
    Adv Drug Deliv Rev; 2020 Dec; 167():19-46. PubMed ID: 33202261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres.
    Li X; Zhang Z; Harris A; Yang L
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1247-1264. PubMed ID: 35863759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.